Obesity and related illnesses claim more than 400,000 lives and account for $150 billion in annual spending on health care in the U.S. alone.
Currently, the only effective, long-term therapy is surgery, such as gastric bypass or gastric banding, which can carry serious risks.
The procedure to implant a gastric electrical stimulators however, are less invasive and offer a simple solution: These can be used to slow the pace at which food empties from the stomach, thereby creating a sensation of fullness and reducing the amount of food consumed.
Obesity is a major worldwide health problem. In the United States, about one-third of the population is obese and more than 15 million patients face such serious health risks from morbid obesity that they need treatment.
Electrical neurostimulation may be the solution many patients have been awaiting globally as a low risk and reversible alternative to dangerous surgical options.
Lone Star NeuroMODULATION
LSN is targeting unmet clinical needs by creating disruptive device platforms that offer promising solutions for lowering costs, realizing higher returns and effectively addressing more therapeutic indications if adopted for medical applications.